Substituted heterocyclic derivatives useful as antidiabetic...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C540S200000

Reexamination Certificate

active

07951793

ABSTRACT:
Compounds are provided which have the structurewhereinZ1is (CH2)qor C═O;Z2is (CH2)por C═O;D is —CH═ or C═O or (CH2)mwhere m is0, 1, 2or3;n=0, 1or2; p=1or2; q=0, 1or2;Q is C or N;X is CH or N;X2is C, N, O or S;X3is C, N, O or S;X4is C, N, O or S;X5is C, N, O or S;X6is C, N, O or S;provided that at least one of X2, X3, X4X5and X6is N; and at least one of X2, X3, X4X5and X6is C; andA, B, R1, R2, R2a, R4, R3, E, Z and Y are as defined herein, which compounds are useful in treating diabetes and related diseases.

REFERENCES:
patent: 5846966 (1998-12-01), Rosenblum et al.
patent: 6143718 (2000-11-01), Kolterman et al.
patent: 6306887 (2001-10-01), Chupak et al.
patent: 6414002 (2002-07-01), Cheng et al.
patent: 0 520 723 (1994-06-01), None
patent: 1 067 109 (2001-01-01), None
patent: A-2001-226350 (2001-08-01), None
patent: WO 92/22533 (1992-12-01), None
patent: WO 95/18130 (1995-07-01), None
patent: WO 96/38415 (1996-12-01), None
patent: WO 97/00258 (1997-01-01), None
patent: WO 97/27847 (1997-08-01), None
patent: WO 97/27857 (1997-08-01), None
patent: WO 97/28137 (1997-08-01), None
patent: WO 97/28149 (1997-08-01), None
patent: WO 97/31907 (1997-09-01), None
patent: WO 98/00137 (1998-01-01), None
patent: WO 98/00403 (1998-01-01), None
patent: WO 98/27974 (1998-07-01), None
patent: WO 99/07357 (1999-02-01), None
patent: WO 99/08501 (1999-02-01), None
patent: WO 99/11255 (1999-03-01), None
patent: WO 99/15520 (1999-04-01), None
patent: WO 99/16758 (1999-04-01), None
patent: WO 99/16770 (1999-04-01), None
patent: WO 99/20275 (1999-04-01), None
patent: WO 99/46232 (1999-09-01), None
patent: WO 00/08002 (2000-02-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 01/21602 (2001-03-01), None
patent: WO 01/38325 (2001-05-01), None
patent: WO 02/096357 (2002-12-01), None
Wolff et. al., “Burger's Medicinal Chemistry and Drug Discovery,” 5th Ed. Part 1, pp. 975-977 (1995).
Banker, et. al., Modern Pharmaceuticals, 2002; p. 596.
Cobb, J.E. et al., “N-(2-Benzoylphenyl)-L-tyrosine PPARγAgonists. 3. Structure-Activity Relationship and Optimization of theN-Aryl Substituent”, J. Med. Chem., vol. 41, pp. 5055-5069 (1998).
Collins, J.L. et al., “N-(2-Benzoylphenyl)-L-tyrosine PPARγAgonists. 2. Structure-Activity Relationship and Optimization of the Phenyl Alkyl Ether Moiety”, J. Med. Chem., vol. 41, pp. 5037-5054 (1998).
Henke, B.R. et al., “N-(2-Benzoylphenyl)-L-tyrosine PPARγAgonists. 1, Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents”, J. Med. Chem., vol. 41, pp. 5020-5036 (1998).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted heterocyclic derivatives useful as antidiabetic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted heterocyclic derivatives useful as antidiabetic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic derivatives useful as antidiabetic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2699480

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.